222 related articles for article (PubMed ID: 20672308)
1. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
Gramoun A; Azizi N; Sodek J; Heersche JN; Nakchbandi I; Manolson MF
J Cell Biochem; 2010 Nov; 111(4):1020-34. PubMed ID: 20672308
[TBL] [Abstract][Full Text] [Related]
2. Bone matrix proteins and extracellular acidification: potential co-regulators of osteoclast morphology.
Gramoun A; Goto T; Nordström T; Rotstein OD; Grinstein S; Heersche JN; Manolson MF
J Cell Biochem; 2010 Oct; 111(2):350-61. PubMed ID: 20506338
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast size heterogeneity in rat long bones is associated with differences in adhesive ligand specificity.
Hu Y; Ek-Rylander B; Karlström E; Wendel M; Andersson G
Exp Cell Res; 2008 Feb; 314(3):638-50. PubMed ID: 18086469
[TBL] [Abstract][Full Text] [Related]
4. IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts.
Trebec-Reynolds DP; Voronov I; Heersche JN; Manolson MF
J Cell Biochem; 2010 Apr; 109(5):975-82. PubMed ID: 20108252
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.
Nilforoushan D; Gramoun A; Glogauer M; Manolson MF
Nitric Oxide; 2009 Aug; 21(1):27-36. PubMed ID: 19389479
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
[TBL] [Abstract][Full Text] [Related]
8. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
[TBL] [Abstract][Full Text] [Related]
9. Ascorbic acid accelerates osteoclast formation and death.
Le Nihouannen D; Barralet JE; Fong JE; Komarova SV
Bone; 2010 May; 46(5):1336-43. PubMed ID: 19932205
[TBL] [Abstract][Full Text] [Related]
10. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
11. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
Yoshida T; Flegler A; Kozlov A; Stern PH
J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
[TBL] [Abstract][Full Text] [Related]
12. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
[TBL] [Abstract][Full Text] [Related]
13. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
Cao Y; Jansen ID; Sprangers S; Stap J; Leenen PJ; Everts V; de Vries TJ
J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
[TBL] [Abstract][Full Text] [Related]
14. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
16. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration.
Brazier H; Pawlak G; Vives V; Blangy A
Int J Biochem Cell Biol; 2009 Jun; 41(6):1391-401. PubMed ID: 19135548
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha and interleukin-1beta modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes.
Bakker AD; Silva VC; Krishnan R; Bacabac RG; Blaauboer ME; Lin YC; Marcantonio RA; Cirelli JA; Klein-Nulend J
Arthritis Rheum; 2009 Nov; 60(11):3336-45. PubMed ID: 19877030
[TBL] [Abstract][Full Text] [Related]
18. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
20. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
